Dabur IndiaDABUR
DABUR logo
Fair Value
₹508.55
Share price01 Aug
₹395.0522.3% undervalued intrinsic discount
Loading
1Y-24.38%
7D-2.09%

DABUR: Expansion Into Digital-First Ventures Will Drive Premiumisation And Earnings

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
19 Nov 24
Updated
01 Aug 26
Views
173
Not Invested

Last Update 01 Aug 26

Fair value Decreased 3.25%

DABUR: Dividend Strength And Acquisition Pipeline Will Support Future Upside

Analysts have trimmed their fair value estimate for Dabur India from about ₹525.62 to roughly ₹508.55, reflecting updated views on its discount rate, revenue growth, profit margin and future P/E assumptions.

What’s in the News for Dabur India

  • Dabur India is actively seeking acquisitions, with management outlining a two step approach of taking minority stakes in new D2C players and potentially increasing to majority holdings if the businesses become profitable. Source: Q1 results investor call comments from Global CEO Mohit Malhotra.
  • The company is currently in discussions with 2 to 3 potential acquisition targets that management views as aligned with its portfolio and not excessively priced, within a broad three year vision to add 1 or 2 sizable companies, subject to deal negotiations and competitive bidding processes.
  • Multiple US FDA enforcement reports show ongoing Class II voluntary recalls of various topical drug products manufactured by Dabur India for third party brands, including antibiotic ointments, antifungal creams and hydrocortisone creams, due to CGMP deviations observed during inspections. Status is reported as ongoing with US wide distribution affected.
  • A board meeting is scheduled for July 29, 2026, to consider and approve Dabur India’s unaudited financial results for the quarter ending June 30, 2026.
  • Dabur India’s board has recommended a final dividend of ₹5.50 per share. The company states that this is in line with its payout policy and takes the total dividend for 2025-26 to a very large percentage of the face value.

Valuation Changes for Dabur India

  • Fair Value has been revised from ₹525.62 to ₹508.55. This reflects a modest reduction in the estimated value per share.
  • Discount Rate moved from 12.84% to 12.67%. This is a small adjustment in the rate used to assess Dabur India’s future cash flows.
  • Revenue Growth assumption shifted from 8.64% to 8.75%. This is a marginal change in the forecast growth rate for revenue in ₹.
  • Net Profit Margin estimate moved from 15.43% to 15.42%. This is a very small adjustment to expected earnings in ₹ as a share of sales.
  • Future P/E multiple has changed from 51.27x to 48.14x. This indicates a slightly lower valuation multiple being applied to Dabur India’s projected earnings.
17 viewsusers have viewed this narrative update

Key Takeaways

  • Market share gains and strong demand across categories, along with health and wellness trends, strengthen Dabur's pricing power and revenue growth outlook.
  • International expansion and ongoing innovation reduce reliance on India, enhance earnings stability, and support margin improvement despite inflationary pressures.
  • Heightened competition, stagnating core segments, weather-driven revenue risks, reduced disclosure, and persistent input inflation all threaten sustained margin and earnings growth.

Catalysts

About Dabur India
    Operates as a fast moving consumer goods company worldwide.
What are the underlying business or industry changes driving this perspective?
  • Continued strong rural and urban demand recovery, coupled with market share gains across key categories (oral care, home care, skin care), positions Dabur to capitalize on India's rising disposable incomes and urbanization, supporting robust future revenue growth.
  • Sustained consumer shift toward Ayurvedic, herbal, and natural products underpins outperformance of the Red franchise and the herbal toothpaste segment, reinforcing Dabur's pricing power and margin potential as health and wellness trends deepen.
  • Significant momentum in international markets (double-digit growth across MENA, Sub-Saharan Africa, US, Europe, Turkey, and Bangladesh) is driving revenue diversification and is likely to reduce dependency on the Indian market, enhancing earnings stability.
  • Ongoing innovation and premiumization-such as expansion into premium variants (Sundarbans and Organic Honey, Real Activ, Health Juices, modernized Hajmola, and Pudin Hara formats)-are expected to improve margins and average selling prices, with management signaling material operating margin improvement for the full year.
  • Continued investment in brand-building, supply chain savings, and cost initiatives enables Dabur to offset inflationary pressures, maintain or increase operating margins, and support steady long-term net profit growth.
Dabur India Earnings and Revenue Growth

Dabur India Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Dabur India's revenue will grow by 8.7% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 14.6% today to 15.4% in 3 years time.
  • Analysts expect earnings to reach ₹26.9 billion (and earnings per share of ₹15.12) by about August 2029, up from ₹19.7 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as ₹30.2 billion.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 48.2x on those 2029 earnings, up from 37.9x today. This future PE is greater than the current PE for the IN Personal Products industry at 35.3x.
  • Analysts expect the number of shares outstanding to grow by 0.09% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 12.67%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Competitive intensity, especially in key categories like Oral Care and Hair Oils, is leading to higher promotional spending and price discounting (e.g., net realization was -1.8% in India), which could continue to squeeze margins if deep-pocketed MNCs and regional players maintain aggressive strategies-risking both net margins and revenue growth.
  • Stagnation in high-margin health care segments (e.g., Honey and Chyawanprash), with management acknowledging a multi-year struggle to surpass the post-COVID base, signals a risk that core categories may have limited long-term growth potential if younger consumers do not adopt these products, impacting overall revenue and margin expansion.
  • Heavy weather-dependency in the beverages and seasonal portfolio (e.g., significant impact from unseasonal rainfall leading to 30–40% declines in Glucose and Juice sales) exposes Dabur's topline to increased volatility due to climate change and unpredictable weather patterns, which could undermine consistent revenue growth.
  • The company's recent decline in disclosure transparency (noted by investors on the call) could erode market confidence and investor trust, potentially suppressing share price due to perceived governance risks or uncertainty regarding underlying financial performance, particularly if volume and primary vs. secondary sales data are less freely reported.
  • Inflationary pressures-particularly in raw materials like edible oils and Amla-are persistently high (projected at 7–8%), making Dabur reliant on continual price increases and cost-saving initiatives to protect gross and operating margins; failure to do so in the face of strong competition, or customer resistance to price hikes, poses a risk to both margins and long-term earnings growth.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of ₹508.55 for Dabur India based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₹625.0, and the most bearish reporting a price target of just ₹379.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be ₹174.3 billion, earnings will come to ₹26.9 billion, and it would be trading on a PE ratio of 48.2x, assuming you use a discount rate of 12.7%.
  • Given the current share price of ₹421.45, the analyst price target of ₹508.55 is 17.1% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Dabur India?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

1 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

₹508.55
vs ₹395.0522.3% undervalued intrinsic discount
PastFuture0174b2015201820212024202620272029Revenue ₹174.3bEarnings ₹26.9b
8.7%
Revenue growth
15.4%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Dabur India

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Solid track record with excellent balance sheet and pays a dividend.

Market cap₹700.8b
PB6.1x
Estimated Growth7.7%
Dividend Yield2.1%
Full analysis

CEO & management

Mohit Malhotra
CEO
3.7yrs
CEO Tenure

Operates as a fast moving consumer goods company worldwide.